Background: The hyperuricaemia in gestational diabetes mellitus (GDM) 
Introduction
Gestational diabetes mellitus (GDM) is defined as carbohydrate intolerance resulting in hyperglycemia, with first onset or detection during pregnancy. 1, 2 Usually initiation of GDM is in middle and late gestational period and continues to term. 3 Glucose intolerance usually returns to normal range within six weeks after delivery. Approximately 1-14% of all pregnancies are complicated by GDM. 4 The prevalence of GDM among Bangladeshi pregnant mothers has been reported as 9.7% . 5 GDM is characterized by insulin resistance, glucose intolerance, hyperlipidaemia, impaired beta cell function and endothelial dysfunction like type 2 diabetes and metabolic syndrom 6 Uric acid is the end product of the purine metabolism. Uric acid can act as a prooxidant and it may thus be a marker of oxidative stress, but it may also have a therapeutic role as an antioxidant. 7 Urate, the soluble form of uric acid, can scavenge the superoxide and the hydroxyl radicals and it can chelate the trasition metals. 8 Hyperuricaemia has been also added to the set of metabolic abnormalities which are associated with insulin resistance and/or hyperinsulinaemia in the metabolic syndrome. 9 The raise uric acid levels in GDM is a component of the metabolic syndrome that reflects insulin resistance. 10 The hyperuricaemia in GDM has been explained to be a component of the metabolic syndrome which reflects insulin resistance. Further hyperuricaemia has been correlated with obesity, dyslipidaemia and diabetes mellitus. 11 Gestational huperuricaemia was found to be significantly associated with a high rate of maternal and foetal complications along with proteinuria and hypertension. 12 Hyperinsulinaemia may activate the sympathetic nervous system and both of them may be independently associated with a reduced urinary excretion of uric acid.
This study was designed to evaluate serum uric acid level among patients with GDM.
Methods
The study was conducted at Mymensingh Medical College Hospital from July 2013 to June 2014 to evaluate the serum level of uric acid in pregnant women with GDM. The study protocol was approved by the institutional review committee and written informed consent was obtained from all the participants prior to their enrolment into this study.
Study population and collection of samples:
Pregnant women, in their second and third trimester, attending the outpatient department of Obstetrics and Gynecology and the Department of Endocrinology of Mymensingh Medical College Hospital were enrolled by purposive sampling technique. Pregnant women with the previous history of diabetes, hypertension and other endocrine disorders were excluded from the study. Data were collected in a predesigned data collection sheet. The variables included were -age, height, weight, duration of gestation, family history of diabetes, previous history of pregnancy and gestational diabetes mellitus. About 5 ml of blood was collected aseptically with venipuncture from all participants for OGTT and estimation of serum uric acid levels.
Estimation of serum glucose and uric acid: Blood glucose was estimated by enzymatic GOD-PAP colorimetric method. 13 GDM was diagnosed on the basis of OGTT as defined in WHO criteria 2013. 1, 14 The cut off value for fasting plasma glucose level was e"6.1 mmol/L or e"7.8 mmol/L 2 hours after glucose load. Serum uric acid was determined by commercial colorimetric assay kits obtained from Japan Institute for the Control of Aging (JaICA), Nikken Seal Co., Ltd, Japan. Serum uric acid by enzymatic method with Uricase as per manufacturer's instruction. 15 The results were analyzed by employing Student's t test and values were expressed as mean ±SD. The level of significance was determined p< 0.5
Results
A total of 172 pregnant women in their second and third trimester were enrolled in the study, of which 86 had GDM and 86 were normoglycemic. Pregnant women without GDM (normoglycemic) were considered as control group. The mean age of GDM and control groups were 28.6±3.2 years and 27.3±3.1 years respectively, while the mean BMI was 26.4±1.5 kg / m 2 and 26.3±1.3 kg / m 2 respectively (Table I) . Serum uric acid levels in GDM cases were significantly (p<0.001) higher in third trimester (4.33 ±0.62 mg/dl) compared to those without GDM (3.52 ±0.74 mg/dl). But there was no significant rise of serum uric acid levels compared to second trimester in both GDM and non GDM cases (Table II) . 
Discussion
Uric acid is filtered by the renal glomeruli, absorbed by the first part of the proximal convoluted tubule, with a further secretion and reabsorption phase. Ten percent of the filtered uric acid is excreted in the urine. During pregnancy, uric acid clearance increases from 6 to 12 mL/min to 12 to 20 mL/min, with a 25% decrease in blood concentration. 9 Elevated serum uric acid level due to decreased renal urate excretion is frequently found in women with preclampsia. 16 Uric acid (as also creatinine and to some extent urea), possesses water soluble or hydrophilic antioxidant characteristics, may delay or inhibit cellular damage mainly through the free radical scavenging property; it also presents strong antioxidant activity towards ROS in aqueous phase. 17 Uric acid contributes to about 60% of free radical scavenging activity in human. 18 The observed uric acid elevation may be a protective response, capable of opposing harmful effects of free radical activity and oxidative stress. Elevated serum uric acid concentrations predict the development of hypertension. 19 Soluble uric acid impairs nitric oxide generation in endothelial cells thus inhibit vascular relaxation. Hence, hyperuricemia can induce endothelial dysfunction (impaired endothelial integrity). 19, 20 It has been proposed that these pregnancy mediated changes in serum uric acid are often the result of altered renal handling. 19, 20, 21 In this study uric acid levels were higher in the GDM patients, this elevation was statistically highly significant. In univariate analysis, gestational hyperuricaemia was found to be significantly associated with a high rate of maternal and fetal complicatons, along with proteinuria and hypertension . 12 Hyperinsulinaemia may activate the sympathetic nervous system and both of them may be independently associated with a reduced urinary excretion of uric acid. Thus, the raised serum uric acid levels may reflect both these mechanisms and some researchers. found that serum uric acid was significantly correlated with insulin resistance. 15, 22 Seghieri et al. (2003) reported that GDM remained significantly associated with higher serum uric acid levels . 16 Our findings is supported by the studies of Danisman and Mollamahmtuglu (2006) . 20 
Conclusion
The present study has revealed that there is pronounced alteration of serum uric acid levels in GDM cases compared to normal pregnancy. Therefore, further study should be done to find out the underlying mechanism of alteration of serum uric acid levels in GDM.
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